Bristol-Myers Squibb

Scientist, QC Microbiology

Posted on: 5 Feb 2021

Devens, MA

Job Description

At Bristol Myers Squibb, we are inspired by a single vision transforming patients lives through science. In oncology, hematology, immunology and cardiovascular disease and one of the most diverse and promising pipelines in the industry each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.

Job Summary

Bristol Myers Squibb is seeking a QC Scientist for QC Microbiology at the Cell Therapy Facility (CTF) in Devens, MA. The QC Scientist is responsible for supporting Quality Control microbiology testing for release of clinical and commercial products and environmental monitoring. This includes the ability to interface with multiple groups, the ability to independently perform tasks, interpret results, and troubleshoot. Additionally, the QC Scientist will assist with training and assay transfer. The QC Scientist role is stationed in Devens, MA and reports to the Head of Micro Operations for the Devens CTF.

Job Responsibilities

* Perform environmental monitoring and testing of in-process, final product, and stability samples.
* Utilize scientific principles to assist in microbiological testing methods and the proper use of laboratory equipment.
* Anticipate and troubleshoot problems.
* Train new analysts to general job duties.
* Complete necessary training to become a qualified trainer.
* Perform training effectively.
* Document training per procedural and cGMP requirements.
* Support document revision, project, CAPA, and investigation/deviation related tasks.
* Perform assigned tasks within a CAPA, deviation, or project.
* Participate in complex projects and continuous improvement efforts.

Qualifications and Education Requirements

* Bachelors degree required, preferable in Science.
* 6+ years of relevant work experience, preferable in a regulated environment.
* An equivalent combination of education and experience may substitute.
* Experience working in clean room environments and with cell therapy products preferred.
* Advanced hands on experience with various microbiology techniques and environmental monitoring.
* Advanced ability to accurately and completely understand, follow, interpret and apply Global Regulatory and cGMP requirements.
* Advanced technical writing skills.
* Advanced problem-solving ability/mentality, technically adept and logical.
* Ability to represent the interests of the group on cross-functional teams.
* Ability to set priorities of the group and manage timelines.
* Ability to work with management locally and globally.
* Advanced ability to communicate effectively with peers, department management and cross- functional peers.
* Working knowledge of LIMS.

Around the world, we are passionate about making an impact on the lives of patients with serious diseases. Empowered to apply our individual talents and diverse perspectives in an inclusive culture, our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.

Bristol-Myers Squibb

New York, New York

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers drugs in oncology, immunoscience, cardiovascular, and fibrotic diseases. The company’s products include Opdivo, a biological product for anti-cancer indications; Eliquis, an oral inhibitor targeted at stroke prevention in adult patients with non-valvular atrial fibrillation, and the prevention and treatment of venous thromboembolic disorders; and Orencia, a biological product for adult patients with moderately to severely active RA and prostate-specific antigen, as well as reducing signs and symptoms in certain pediatric patients with moderately to severely active polyarticular juvenile idiopathic arthritis.

It also provides Sprycel, a tyrosine kinase inhibitor for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma; Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma; and Baraclude, an oral antiviral agent for the treatment of chronic hepatitis B. In addition, the company offers Reyataz, a protease inhibitor for the treatment of human immunodeficiency virus (HIV) and Evotaz; Sustiva franchise, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV; and Daklinza NS5A replication complex inhibitor, Sunvepra NS3 protease inhibitor, and Beclabuvir NS5B inhibitor. It sells products to wholesalers, retail pharmacies, hospitals, government entities, and medical profession. It has collaboration agreements with Nektar Therapeutics; Janssen Pharmaceuticals, Inc.; Biocartis Group NV.; and FameWave Ltd.

The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York.

  • Industry
    Biopharmaceuticals
  • No. of Employees
    23, 300
  • Jobs Posted
    1641